Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    89bio Inc.

    NASDAQ: ETNB · Real-Time Price · USD
    10.03
    -0.38 (-3.65%)
    At close: Jun 16, 2025, 3:59 PM
    10.56
    5.34%
    After-hours: Jun 16, 2025, 06:49 PM EDT

    89bio Statistics

    Share Statistics

    89bio has 145.98M shares outstanding. The number of shares has increased by 48.38% in one year.

    Shares Outstanding

    n/a
    		 145.98M

    Shares Change (YoY)

    n/a
    		 48.38%

    Shares Change (QoQ)

    n/a
    		 24.16%

    Owned by Institutions (%)

    n/a
    		 99.99%

    Shares Floating

    n/a
    		 141.29M

    Failed to Deliver (FTD) Shares

    n/a
    		 13,664

    FTD / Avg. Volume

    n/a
    		 0.63%

    Short Selling Information

    The latest short interest is 13.93M, so 9.55% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 13.93M

    Short % of Shares Out

    n/a
    		 9.55%

    Short % of Float

    n/a
    		 13.29%

    Short Ratio (days to cover)

    n/a
    		 5.84

    Valuation Ratios

    The PE ratio is -2.23 and the forward PE ratio is -4.62. 89bio's PEG ratio is -0.03.

    PE Ratio

    n/a
    		 -2.23

    Forward PE

    n/a
    		 -4.62

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 1.3

    PB Ratio

    n/a
    		 2.04

    P/FCF Ratio

    n/a
    		 -2.23

    PEG Ratio

    n/a
    		 -0.03
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for 89bio.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 13.19, with a Debt / Equity ratio of 0.09.

    Current Ratio

    n/a
    		 13.19

    Quick Ratio

    n/a
    		 13.19

    Debt / Equity

    n/a
    		 0.09

    Debt / EBITDA

    n/a
    		 -0.1

    Debt / FCF

    n/a
    		 -0.1

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-3,947,086.02

    Employee Count

    n/a
    		 93

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 692K

    Effective Tax Rate

    n/a
    		 -0.19%

    Stock Price Statistics

    The stock price has increased by 13.21% in the last 52 weeks. The beta is 1.53, so 89bio's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.53

    52-Week Price Change

    n/a
    		 13.21%

    50-Day Moving Average

    n/a
    		 8.07

    200-Day Moving Average

    n/a
    		 8.33

    Relative Strength Index (RSI)

    n/a
    		 57.82

    Average Volume (20 Days)

    n/a
    		 2,162,820

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -384.66M

    Net Income

    n/a
    		 -367.08M

    EBITDA

    n/a
    		 -384.66M

    EBIT

    n/a
    		 -371.68M

    Earnings Per Share (EPS)

    n/a
    		 -3.51
    Full Income Statement

    Balance Sheet

    The company has 126.06M in cash and 37.55M in debt, giving a net cash position of 88.51M.

    Cash & Cash Equivalents

    n/a
    		 126.06M

    Total Debt

    n/a
    		 37.55M

    Net Cash

    n/a
    		 88.51M

    Retained Earnings

    n/a
    		 -824.51M

    Total Assets

    n/a
    		 685.03M

    Working Capital

    n/a
    		 645.06M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -367.82M and capital expenditures -15K, giving a free cash flow of -367.84M.

    Operating Cash Flow

    n/a
    		 -367.82M

    Capital Expenditures

    n/a
    		 -15K

    Free Cash Flow

    n/a
    		 -367.84M

    FCF Per Share

    n/a
    		 -3.51
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    ETNB does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for ETNB is $25, which is 149.3% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $25

    Price Target Difference

    n/a
    		 149.3%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 8
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 7.62

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist